Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

KV Pharmaceutical (ANDA)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Abbreviated New Drug Application (ANDA) for acne gel. The ANDA refers to the clindamycin phosphate (1%) and benzoyl peroxide (5%) gel, which is used for the topical treatment of inflammatory acne vulgaris.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Medical Supplies
Other Industries
Other Commercial Services
Acquirer
Primary Office
  • 16640 Chesterfield Grove Road
  • Suite 200
  • Chesterfield, MO 63005
  • United States

KV Pharmaceutical (ANDA) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore KV Pharmaceutical (ANDA)‘s full profile, request access.

Request full access to PitchBook

KV Pharmaceutical (ANDA) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore KV Pharmaceutical (ANDA)‘s full profile, request access.

Request full access to PitchBook